Related Experiment Videos

Regulation of osteoclastic acid secretion by cGMP-dependent protein kinase

C Van Epps-Fung1, J P Williams, T L Cornwell

  • 1Department of Pathology, University of Alabama at Birmingham 35294.

Insights

Nitric oxide (NO) regulates bone turnover by inhibiting osteoclast activity. This study shows NO works via cyclic guanosine monophosphate (cGMP)-dependent protein kinase to directly block acid secretion in osteoclasts.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Bone Physiology

Background:

  • Nitric oxide (NO) is known to reduce osteoclast activity, a key process in bone remodeling.
  • The precise molecular mechanisms underlying NO's effect on osteoclasts remain largely unelucidated.
  • NO often signals through cyclic guanosine monophosphate (cGMP)-dependent pathways in various cell types.

Purpose of the Study:

  • To investigate the presence and function of cGMP-dependent protein kinase (PKG) in osteoclasts.
  • To determine if PKG plays a role in the NO-mediated regulation of osteoclast function, specifically HCl secretion.

Main Methods:

  • Immunofluorescence microscopy was used to detect PKG in isolated avian osteoclasts.
  • Western blot analysis confirmed the identity and size of PKG in osteoclasts.
  • Functional assays using reconstituted osteoclast membrane vesicles assessed the effect of PKG on ATP-dependent acid transport.

Main Results:

  • cGMP-dependent protein kinase (PKG) was identified in osteoclasts via immunofluorescence and confirmed as the Type I isoform by Western blot.
  • Purified PKG significantly inhibited ATP-dependent acid transport in osteoclast membrane vesicles by over 90%.
  • Other tested agents, including cAMP-dependent kinase, calmodulin kinase II, and cGMP alone, did not inhibit acid transport.

Conclusions:

  • This study demonstrates that cGMP-dependent protein kinase (PKG) is present in osteoclasts and directly inhibits their acid transport function.
  • These findings suggest a novel mechanism where nitric oxide (NO) regulates bone turnover by activating the cGMP-PKG pathway, leading to inhibition of osteoclast HCl secretion.

Related Concept Videos